{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:37:08Z","timestamp":1763746628553},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jns.2007.02.017","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:16:30Z","timestamp":1174994190000},"page":"61-67","source":"Crossref","is-referenced-by-count":14,"title":["Effective treatment of experimental autoimmune neuritis with human immunoglobulin"],"prefix":"10.1016","volume":"256","author":[{"given":"Hsin Hsin","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Spies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Lan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Immunopathogenesis and treatment of the Guillain\u2013Barr\u00e9 syndrome\u2014Part I","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.jns.2007.02.017_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00019052-199810000-00013","article-title":"Guillain\u2013Barr\u00e9 syndrome, CIDP and other chronic immune-mediated neuropathies","volume":"11","author":"Hartung","year":"1998","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.jns.2007.02.017_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00019052-200210000-00013","article-title":"Animal models of immune-mediated neuropathies","volume":"15","author":"M\u00e4urer","year":"2002","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","article-title":"Animal models for autoimmune demyelinating disorders of the nervous system","volume":"6","author":"Gold","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1016\/j.jns.2007.02.017_bib5","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain\u2013Barr\u00e9 syndrome","volume":"27 Suppl","author":"Hartung","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.02.017_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.neuro.21.1.187","article-title":"Human autoimmune neuropathies","volume":"21","author":"Ho","year":"1998","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.jns.2007.02.017_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain\u2013Barr\u00e9 syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(99)00048-X","article-title":"Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis","volume":"97","author":"Fujioka","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-5728(00)00323-4","article-title":"Sequential expression of chemokines in experimental autoimmune neuritis","volume":"110","author":"Kieseier","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2003.12.024","article-title":"In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging","volume":"149","author":"Stoll","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.jns.2007.02.017_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0960-8966(01)00302-9","article-title":"Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models","volume":"12","author":"M\u00e4urer","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2007.02.017_bib14","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome","volume":"1","author":"Hughes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jns.2007.02.017_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","article-title":"The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile","volume":"102","author":"Dalakas","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(97)00039-8","article-title":"Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat","volume":"76","author":"Enders","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"Pt 9","key":"10.1016\/j.jns.2007.02.017_bib17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/120.9.1533","article-title":"Human immunoglobulin ameliorates rat experimental autoimmune neuritis","volume":"120","author":"Gabriel","year":"1997","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2007.02.017_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain: method of myelin isolation","volume":"21","author":"Norton","year":"1973","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-5728(94)00164-J","article-title":"Synergy between antibody and P2-reactive T cells in experimental allergic neuritis","volume":"57","author":"Spies","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.jns.2007.02.017_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.410370409","article-title":"Activated T cells of nonneural specificity open the blood\u2013nerve barrier to circulating antibody","volume":"37","author":"Pollard","year":"1995","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jns.2007.02.017_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0014-4886(85)90262-6","article-title":"Lumbar-spinal somatosensory evoked potentials in the rat after stimulation of the tibial nerve","volume":"89","author":"Wieth\u00f6lter","year":"1985","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.jns.2007.02.017_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp.55.10.909","article-title":"Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study","volume":"55","author":"Harvey","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2007.02.017_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410230403","article-title":"The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line","volume":"23","author":"Heininger","year":"1988","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5728(97)00090-8","article-title":"Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis","volume":"78","author":"Miyagi","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90240-0","article-title":"Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat","volume":"83","author":"Hartung","year":"1987","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-5728(90)90027-K","article-title":"The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A","volume":"28","author":"McCombe","year":"1990","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jns.2007.02.017_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2249.1999.00768.x","article-title":"Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses","volume":"115","author":"Zhu","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jaut.1999.0317","article-title":"Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10","volume":"13","author":"Di Marco","year":"1999","journal-title":"J Autoimmun"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2007.02.017_bib29","first-page":"S114","article-title":"Effective prevention and treatment of experimental autoimmune neuritis with Rapamycin","volume":"199","author":"Lin","year":"2002","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.jns.2007.02.017_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jns.2007.02.017_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jns.2007.02.017_bib32","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V100.6.2087","article-title":"Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia","volume":"100","author":"Hansen","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jns.2007.02.017_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2249.2005.02947.x","article-title":"Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris","volume":"142","author":"Mimouni","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI117012","article-title":"Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion","volume":"93","author":"Achiron","year":"1994","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.jns.2007.02.017_bib35","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/intimm\/5.12.1559","article-title":"Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis","volume":"5","author":"Saoudi","year":"1993","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.jns.2007.02.017_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/exmp.2001.2382","article-title":"The effect of intravenous immunoglobulins on the progression of experimental autoimmune myocarditis in the rat","volume":"71","author":"George","year":"2001","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"10.1016\/j.jns.2007.02.017_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.10205","article-title":"Intravenous immunoglobulins neutralize blocking antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"51","author":"Buchwald","year":"2002","journal-title":"Ann Neurol"},{"issue":"Pt 10","key":"10.1016\/j.jns.2007.02.017_bib38","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awg235","article-title":"Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding","volume":"126","author":"Jacobs","year":"2003","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2007.02.017_bib39","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.jns.2007.02.017_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-5728(02)00430-7","article-title":"Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcgammaRII expression in patients with chronic inflammatory neuropathies","volume":"135","author":"Cr\u00e9ange","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2007.02.017_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1994.tb00854.x","article-title":"Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy","volume":"139","author":"Abe","year":"1994","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.jns.2007.02.017_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1398-9995.2003.00239.x","article-title":"IVIG\u2014mechanisms of action","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jns.2007.02.017_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jnr.10104","article-title":"Differential regulation of myelin phagocytosis by macrophages\/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins","volume":"67","author":"Kuhlmann","year":"2002","journal-title":"J Neurosci Res"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07001372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07001372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:31:04Z","timestamp":1683783064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X07001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0022510X07001372"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.02.017","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}